These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18947520)

  • 21. Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.
    Hollingsworth R; El Guerche-Séblain C; Tsai T; Vasiliev Y; Lee S; Bright H; Barbosa P
    Influenza Other Respir Viruses; 2021 Jan; 15(1):164-174. PubMed ID: 32885610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
    Stuurman AL; Levi M; Beutels P; Bricout H; Descamps A; Dos Santos G; McGovern I; Mira-Iglesias A; Nauta J; Torcel-Pagnon L; Biccler J;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13087. PubMed ID: 36550627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
    Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.
    Straetemans M; Buchholz U; Reiter S; Haas W; Krause G
    BMC Public Health; 2007 Sep; 7():236. PubMed ID: 17825095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.
    Kissling E; Valenciano M;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project.
    Paget J; Danielle Iuliano A; Taylor RJ; Simonsen L; Viboud C; Spreeuwenberg P;
    Vaccine; 2022 Feb; 40(9):1361-1369. PubMed ID: 35094868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A; Ammon A; Amato Gauci A; Ciancio B; Zucs P; Devaux I; Plata F; Mazick A; Mølbak K; Asikainen T; Kramarz P
    Public Health; 2010 Jan; 124(1):14-23. PubMed ID: 20141821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain.
    Savulescu C; Valenciano M; de Mateo S; Larrauri A;
    Vaccine; 2010 Apr; 28(16):2903-7. PubMed ID: 20153351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
    Halme J; Syrjänen RK; Baum U; Palmu AA
    Vaccine; 2022 Jul; 40(31):4242-4252. PubMed ID: 35691869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
    Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
    Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009).
    Amour S; Voirin N; Regis C; Bouscambert-Duchamp M; Comte B; Coppéré B; Pires-Cronenberger S; Lina B; Vanhems P
    Vaccine; 2012 Jan; 30(5):821-4. PubMed ID: 22138212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
    Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.
    Savulescu C; Jiménez-Jorge S; de Mateo S; Ledesma J; Pozo F; Casas I; Larrauri A;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
    Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A
    Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project.
    Carmona A; Muñoz-Quiles C; Stuurman A; Descamps A; Mira-Iglesias A; Torcel-Pagnon L; Díez-Domingo J
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33504081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.